This month many of you will be participating in activities to raise awareness among your individual communities about multiple sclerosis—its impact on your life and the lives of others you care about, and the state of scientific knowledge about the disease that may lead to treatments and cures. In spite of considerable investments by the federal government, non-profits and industry, the exact cause of MS remains unknown, there are no diagnostic laboratory tests available and there is no cure. I hope you will take a few minutes this month, as you get together with friends and family, to talk about myelin repair and the hope it offers so many with MS for whom immunosuppressant therapies alone have failed to hold the disease at bay
See the original post here:
URL: http://www.youtube.com/watch?v=A2KkBQQ7UKg
Related Post
- Taiwan Medical Expertise Supports Global Health: A Case of Rebirth - May 18th, 2012
- Study Shows MS Patients at Most Risk for Drug-Linked Brain Illness - May 18th, 2012
- Smoking pot may help relieve MS pain - May 15th, 2012
- Study: Marijuana may help with MS symptoms - May 15th, 2012
- Marijuana May Help Relieve MS Patients' Symptoms - May 15th, 2012
- FDA Warns MS Stent Treatment Unproven, Possibly Deadly - May 15th, 2012
- New MS treatment may cause death: FDA - May 13th, 2012
- FDA Issues Warning On Unproven MS Treatment - May 13th, 2012
- U.S. regulator issues alert on dangers of controversial MS treatment - May 13th, 2012
- Hundreds take part in local Walk MS - May 10th, 2012
- Ann Romney: Shock of MS diagnosis - May 10th, 2012
- Misdiagnosis of MS more common than previously thought - May 10th, 2012
- Why hundreds of patients a year are misdiagnosed with MS - May 10th, 2012
- U.S. FDA warns of injuries, deaths linked to 'liberation therapy' for MS - May 10th, 2012
- OHSU study: Misdiagnosis of MS is costing health system millions per year - May 10th, 2012
- U.S. FDA warns of injuries, deaths linked to 'liberation therapy' for multiple sclerosis - May 10th, 2012
- FDA warns MS patients about risky treatment - May 10th, 2012
- FDA Issues Warning on Controversial MS Treatment - May 10th, 2012
- CCSVI and MS Update - After the Move, May 5, 2012 - Video - May 7th, 2012
- Wonderful Day For A Walk - May 7th, 2012
- Walk MS arrives in Plattsburgh - May 6th, 2012
- Ukraine treatment for Tymoshenko - May 6th, 2012
- Wellsville Multiple Sclerosis Walk: Marlee Cannon, Diane Winans doing their parts for MS awareness - May 6th, 2012
- UQ turns red to raise awareness of MS - May 3rd, 2012
- Walkers wanted - May 3rd, 2012
- MS questions and answers - May 3rd, 2012
- New MS drug shows promise - May 3rd, 2012
- Bonnie and Ken Shockey encourage cancer patients to research Low Dose Naltrexone - April 29th, 2012
- Multiple Sclerosis: Symptoms and Treatment - Video - April 24th, 2012
- Proof Ccsvi Treatment IS Effective -- Dr Mark Haacke - Video - April 24th, 2012
- Gilenya Successfully Treated Relapsing MS Patients For Up To 7 Years - April 24th, 2012
- MS Drug Gilenya Positive Benefit-Risk Profile Following CHMP Review, Europe - April 24th, 2012
- OHIP shouldn’t pay for Ottawa-area woman’s controversial MS treatment, says tribunal - April 24th, 2012
- StudioPMG's "Challenge Walk MS Documentary" Lands Spot in Prestigious Newport Beach Film Festival - April 24th, 2012
- New Warnings for MS Drug Gilenya After FDA Review - April 24th, 2012
- Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS - April 20th, 2012
- Opexa to Hold Preliminary Investigator’s Meeting for MS Trial at American Academy of Neurology Annual Meeting - April 20th, 2012
- Novartis updates US label on Gilenya® following discussions with the FDA - April 20th, 2012
- Event slated to support MS treatment and research - April 20th, 2012
- Genzyme Demonstrates Depth of MS Pipeline at AAN with Results from Multiple Sclerosis Phase lll Trials - April 20th, 2012
